🇺🇸 FDA
Pipeline program

SPN-804O

804P107

Phase 1 small_molecule completed

Quick answer

SPN-804O for Epilepsies, Partial is a Phase 1 program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
SUPERNUS PHARMACEUTICALS, INC.
Indication
Epilepsies, Partial
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials